Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             39 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Additional Cytogenetic Abnormalities with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era Akahoshi, Yu

24 10 p. 2009-2016
artikel
2 A Modified Intensive Strategy to Prevent Cytomegalovirus Disease in Seropositive Umbilical Cord Blood Transplantation Recipients Hill, Joshua Aiden

24 10 p. 2094-2100
artikel
3 Analysis of Clinical Factors and Outcomes Associated with Nonuse of Collected Peripheral Blood Stem Cells for Autologous Stem Cell Transplants in Transplant-Eligible Patients with Multiple Myeloma Kansagra, Ankit

24 10 p. 2127-2132
artikel
4 ASBMT News
24 10 p. 2169-2170
artikel
5 Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75 Sidiqi, M. Hasib

24 10 p. 2157-2159
artikel
6 CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes de Lima, Marcos

24 10 p. 2017-2024
artikel
7 Chromosomal Aberrations and Survival after Unrelated Donor Hematopoietic Stem Cell Transplant in Patients with Fanconi Anemia Wang, Youjin

24 10 p. 2003-2008
artikel
8 Comparative Efficacy and Safety of Different Antiviral Agents for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis Gagelmann, Nico

24 10 p. 2101-2109
artikel
9 Cost Effectiveness of Hematopoietic Stem Cell Transplantation Compared with Transfusion Chelation for Treatment of Thalassemia Major John, M. Joseph

24 10 p. 2119-2126
artikel
10 Cytomegalovirus Infection Among Cord Blood Allogeneic Transplantation Recipients: Low Incidence of Cytomegalovirus Events without High-Dose Valacyclovir Prophylaxis Knoll, Bettina M.

24 10 p. 2164-2165
artikel
11 Defining Incidence and Risk Factors for Catheter-Associated Bloodstream Infections in an Outpatient Adult Hematopoietic Cell Transplantation Program McDonald, Marissa K.

24 10 p. 2081-2087
artikel
12 Deleterious Effect of Steroids on Cytomegalovirus Infection Rate after Allogeneic Stem Cell Transplantation Depends on Pretransplant Cytomegalovirus Serostatus of Donors and Recipients Suárez-Lledó, María

24 10 p. 2088-2093
artikel
13 Dysfunctional Bone Marrow Mesenchymal Stem Cells in Patients with Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation Song, Yang

24 10 p. 1981-1989
artikel
14 Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes McCurdy, Shannon R.

24 10 p. 2056-2064
artikel
15 Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study Spellecy, Ryan

24 10 p. 2145-2151
artikel
16 Editorial Board
24 10 p. A6
artikel
17 Expression of Intracellular Reactive Oxygen Species in Hematopoietic Stem Cells Correlates with Time to Neutrophil and Platelet Engraftment in Patients Undergoing Autologous Bone Marrow Transplantation Bai, Lijun

24 10 p. 1997-2002
artikel
18 Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies Katsanis, Emmanuel

24 10 p. 2034-2039
artikel
19 Haploidentical Transplants: An Answer to Ethical Challenges on the Use of Preimplantation Donor Selection Rondelli, Damiano

24 10 p. 2167-2168
artikel
20 Hematogones Predict Better Outcome in Allogeneic Hematopoietic Stem Cell Transplantation Irrespective of Graft Sources Ishio, Takashi

24 10 p. 1990-1996
artikel
21 Higher CD45RA+ Regulatory T Cells in the Graft Improves Outcome in Younger Patients Undergoing T Cell–Replete Haploidentical Transplantation: Where Donor Age Matters Jaiswal, Sarita Rani

24 10 p. 2025-2033
artikel
22 Initial High Viral Load Is Associated with Prolonged Shedding of Human Rhinovirus in Allogeneic Hematopoietic Cell Transplant Recipients Ogimi, Chikara

24 10 p. 2160-2163
artikel
23 It's Not All in the Conditioning or the Perils of Early Trial Cessation Scott, Bart L.

24 10 p. 1957-1958
artikel
24 Masthead (Purpose and Scope)
24 10 p. A4
artikel
25 Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease Fan, Xiubo

24 10 p. 1971-1980
artikel
26 Officers and Directors of ASBMT
24 10 p. A8
artikel
27 Outcomes of Measurable Residual Disease in Pediatric Acute Myeloid Leukemia before and after Hematopoietic Stem Cell Transplant: Validation of Difference from Normal Flow Cytometry with Chimerism Studies and Wilms Tumor 1 Gene Expression Jacobsohn, David A.

24 10 p. 2040-2046
artikel
28 Outcomes of Relapsed and Refractory Primary Mediastinal (Thymic) Large B Cell Lymphoma Treated with Second-Line Therapy and Intent to Transplant Vardhana, Santosha

24 10 p. 2133-2138
artikel
29 Peritransplantation Ruxolitinib Prevents Acute Graft-versus-Host Disease in Patients with Myelofibrosis Undergoing Allogenic Stem Cell Transplantation Kröger, Nicolaus

24 10 p. 2152-2156
artikel
30 Propensity Score Analysis of Conditioning Intensity in Peripheral Blood Haploidentical Hematopoietic Cell Transplantation Huselton, Eric

24 10 p. 2047-2055
artikel
31 Providing Level-of-Match Information to Perfectly Matched Unrelated Stem Cell Donors: Evaluating Acceptability and Potential Changes in Donor Availability Switzer, Galen E.

24 10 p. 2110-2118
artikel
32 Randomized, Placebo-Controlled, Phase III Trial of Fosaprepitant, Ondansetron, Dexamethasone (FOND) Versus FOND Plus Olanzapine (FOND-O) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematologic Malignancies Receiving Highly Emetogenic Chemotherapy and Hematopoietic Cell Transplantation Regimens: The FOND-O Trial Clemmons, Amber B.

24 10 p. 2065-2071
artikel
33 Relationship between Aging and Hematopoietic Cell Transplantation Cupit-Link, Margaret C.

24 10 p. 1965-1970
artikel
34 Reply to Author Hill, Joshua A.

24 10 p. 2166
artikel
35 Risk Score for the Development of Veno-Occlusive Disease after Allogeneic Hematopoietic Cell Transplant Strouse, Christopher

24 10 p. 2072-2080
artikel
36 Safety and Efficacy of Once-Daily Intravenous Busulfan in Allogeneic Transplantation: A Matched-Pair Analysis Kako, Shinichi

24 10 p. 2139-2144
artikel
37 Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation Sullivan, Keith M.

24 10 p. 1961-1964
artikel
38 Table of Contents
24 10 p. A9-A14
artikel
39 Ten Things to Know About Primary Mediastinal B Cell Lymphoma Avivi, Irit

24 10 p. 1959-1960
artikel
                             39 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland